Literature DB >> 28011379

Heart targeted nanoliposomal/nanoparticles drug delivery: An updated review.

Mostafa Cheraghi1, Babak Negahdari2, Hadis Daraee3, Ali Eatemadi4.   

Abstract

Nanoliposomes are type of nano-sized vesicles made of bi-layered phospholipid membranes with an aqueous interior. They have been demonstrated to deliver several materials like low molecular weight drugs, imaging agents, peptides, proteins, and nucleic acids. Nanoliposomes have been demonstrated to slowly release an encapsulated drug, thereby leading to sustained exposure to target region and improved efficacy. This ability of nano-liposomes can be harnessed to deliver therapeutic agents precisely to the infarcted heart. Accordingly, this article will review recent developments in the application of nano liposomes and nanoparticles as drug delivery systems to treat cardiovascular related disorders such as atherosclerosis, restenosis and myocardial infarction.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Myocardial infarction; Nano-liposomes; Nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 28011379     DOI: 10.1016/j.biopha.2016.12.009

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Drug Delivery and Nanoformulations for the Cardiovascular System.

Authors:  W J Geldenhuys; M T Khayat; J Yun; M A Nayeem
Journal:  Res Rev Drug Deliv       Date:  2017-03-07

2.  Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.

Authors:  Jianjun Yu; Wei Li; Dongmei Yu
Journal:  Drug Des Devel Ther       Date:  2018-06-11       Impact factor: 4.162

Review 3.  Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.

Authors:  Antonio Cervadoro; Roberto Palomba; Giuseppe Vergaro; Roberta Cecchi; Luca Menichetti; Paolo Decuzzi; Michele Emdin; Stefano Luin
Journal:  Front Bioeng Biotechnol       Date:  2018-11-27

Review 4.  The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Željko Reiner; Federico Carbone; Fabrizio Montecucco; Amirhossein Sahebkar
Journal:  Biomolecules       Date:  2019-08-26

5.  Evaluation of upconverting nanoparticles towards heart theranostics.

Authors:  Marc Kermorgant; Jennifer Ben Salem; Julien Santelli; Denis Calise; Anne-Cécile Oster; Olivier Lairez; Christophe Coudret; Marc Verelst; Céline Gales; Jean-Michel Sénard; Francis Beaudry; Anne Pavy-Le Traon; Clément Roux; Robert Mauricot; Dina N Arvanitis
Journal:  PLoS One       Date:  2019-12-09       Impact factor: 3.240

Review 6.  Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction.

Authors:  Qingbo Lv; Boxuan Ma; Wujiao Li; Guosheng Fu; Xiaoyu Wang; Yun Xiao
Journal:  Front Chem       Date:  2022-07-07       Impact factor: 5.545

7.  A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases.

Authors:  Alessandra Marrella; Michele Iafisco; Alessio Adamiano; Stefano Rossi; Maurizio Aiello; Maria Barandalla-Sobrados; Pierluigi Carullo; Michele Miragoli; Anna Tampieri; Silvia Scaglione; Daniele Catalucci
Journal:  J R Soc Interface       Date:  2018-07       Impact factor: 4.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.